Aristotle Atlantic Partners’s Bristol-Myers Squibb BMY Stock Holding History

Aristotle Atlantic Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07M	Hold	18,600	–	–	0.04%	88
2026 Q1	$1.13M	Buy	+18,600	New	+$1.08M	0.05%	84
2025 Q2	–	Sell	-3,600	Closed	-$220K	–	86
2025 Q1	$220K	Hold	3,600	–	–	0.01%	88
2024 Q4	$204K	Buy	+3,600	New	+$201K	0.01%	90
2023 Q4	–	Sell	-226,267	Closed	-$13.1M	–	97
2023 Q3	$13.1M	Sell	226,267 -5,491	-2%	-$336K	0.53%	57
2023 Q2	$14.8M	Buy	231,758 +57,033	+33%	+$3.82M	0.56%	55
2023 Q1	$12.1M	Buy	174,725 +981	+0.6%	+$69.2K	0.62%	55
2022 Q4	$12.5M	Buy	173,744 +669	+0.4%	+$50.4K	0.7%	47
2022 Q3	$12.3M	Buy	173,075 +1,281	+0.7%	+$92.9K	0.75%	46
2022 Q2	$13.2M	Buy	171,794 +33,684	+24%	+$2.57M	1.02%	27
2022 Q1	$10.1M	Buy	138,110 +3,680	+3%	+$247K	0.62%	40
2021 Q4	$8.38M	Sell	134,430 -31,655	-19%	-$1.86M	0.49%	49
2021 Q3	$9.83M	Buy	166,085 +2,336	+1%	+$154K	0.65%	38
2021 Q2	$10.9M	Buy	163,749 +3,257	+2%	+$212K	0.72%	35
2021 Q1	$10.1M	Buy	160,492 +32,559	+25%	+$2.03M	0.74%	37
2020 Q4	$7.93M	Buy	127,933 +964	+0.8%	+$59.3K	0.61%	39
2020 Q3	$7.66M	Buy	126,969 +1,006	+0.8%	+$60.5K	0.67%	37
2020 Q2	$7.41M	Buy	125,963 +3,419	+3%	+$205K	0.71%	36
2020 Q1	$6.83M	Buy	122,544 +760	+0.6%	+$46.5K	1.04%	31
2019 Q4	$7.82M	Buy	+121,784	New	+$6.97M	1%	33
2018 Q4	–	Sell	-3,600	Closed	-$223K	–	88
2018 Q3	$223K	Buy	+3,600	New	+$214K	0.14%	41
2018 Q2	–	Sell	-3,600	Closed	-$228K	–	85
2018 Q1	$228K	Hold	3,600	–	–	0.08%	84
2017 Q4	$221K	Buy	+3,600	New	+$225K	0.08%	81

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Aristotle Atlantic Partners's BMY Position: Q2 2026 in Review

Aristotle Atlantic Partners held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 18,600 shares worth $1.07M. The position accounts for 0.04% of the portfolio, ranked #88.

Aristotle Atlantic Partners first reported a position in BMY in Q4 2017 and has held it in 23 quarters since. The position peaked at $14.8M in Q2 2023. 2,516 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Aristotle Atlantic Partners held 18,600 shares of Bristol-Myers Squibb worth $1.07M as of Q2 2026.
Aristotle Atlantic Partners left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.04% of Aristotle Atlantic Partners's portfolio in Q2 2026, its #88 holding.
Aristotle Atlantic Partners first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 23 quarters since.
Aristotle Atlantic Partners's Bristol-Myers Squibb position peaked at $14.8M in Q2 2023.
2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2026, filed 14 Aug 2026.